[Efalizumab-induced aseptic meningitis].
Rivas-Rodríguez
R
R
Romero-Alonso
M M
MM
Gabella-Bazarot
E
E
Sánchez-Gómez
E
E
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008582:Meningitis, Aseptic / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab